Benzyl Benzoate
CAS 120-51-4
Benzyl Benzoate (CAS 120-51-4) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 13 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 29448.48153846154 nM | 65 | - |
| - | Potency | 23732.733333333334 nM | 15 | - |
| - | IC50 | 29 | 7 | - |
| - | IC50 | 32763.155 nM | 3 | - |
| - | EC50 | 0.025 g/m2 | 1 | - |
| Beta-lactamase Enzyme |
IC50 | 4.05 | - | Escherichia coli (strain K12) |
| Hormone-sensitive lipase Enzyme |
IC50 | 5.96 | - | Rattus norvegicus |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BENZYL BENZOATE | 19044 | SU | MTHSPL |
| Benzyl Benzoate | 19044 | SU | MTHSPL |
| benzyl benzoate | 19044 | SU | MTHSPL |
| benzyl benzoate | 19044 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Benzyl Benzoate used for in pharmaceutical contexts?
Benzyl Benzoate (CAS 120-51-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Benzyl Benzoate?
Benzyl Benzoate has 13 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Cholecystectomy, Condition aggravated, Drug ineffective, Eye irritation, Off label use. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Benzyl Benzoate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Benzyl Benzoate with EU status "restricted".
What clinical phase is Benzyl Benzoate in?
Benzyl Benzoate is rendered with ChEMBL max phase 4 (approved).
What bioactivity targets are documented for Benzyl Benzoate?
Benzyl Benzoate has 7 bioactivity rows in this page query. Rendered target entries include Beta-lactamase, Hormone-sensitive lipase.